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Abstract
Drug addiction is a dangerous condition that is the concern of human societies. Nevertheless, several issues exist
ahead of people with a drug use disorder during addiction. Accordingly, various types of studies have been conducted to
understand better the problems that people with a drug use disorder encountered. People with a drug use disorder
usually have a problem tolerating the withdrawal period and some relapse to drug abuse. Complementary studies
further revealed that some hormones like oxytocin (OXT), vasopressin, hypothalamic-pituitary-adrenal axis (HPA) axis
hormones, sex hormones, thyroid hormones, and nutritional hormones are probably involved in addiction processes.
These hormones completely with different mechanisms can inﬂuence drug users’ ultimate outcome. As we will see,
these hormones inﬂuence tolerance, sensitization, and compulsive drug seeking and taking behavior. In this review,
they have been further discussed.
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1. Introduction

D

rug addiction is a severe socio-economical
problem and plenty of studies have been
done to reveal the complex aspects of this problem [1]. The foremost downside that people with a
drug use disorder encounter is to progression to
uncontrolled use of those substances [2]. The
monoaminergic and cholinergic systems are the
most important systems for investigating these
types of behaviors. In different sets of studies
especially with cocaine in human subjects, these
brain systems have been shown to be important
for modulation of some important neuronal
pathways. These are the coeruleo-cortical noradrenergic system that regulates divided and selective attention, the basal forebrain cholinergic
system that is important for stimulus detection,
and the mesostriatal and mesolimbic dopaminergic systems that are important in rewardregulated behaviors. Psychotropic drugs make

some changes in the reward circuit and perhaps
another alternative part of the brain that renders
individuals to develop full manifestation of uncontrolled addiction [3]. These modiﬁcations are
the changes in the degree of tolerance, the
emergence of sensitization, and changing the afﬁnity of drug-receptors. Accordingly, some hormones such as neurohypophyseal hormones and
sex hormones have recently been shown in
different studies both in animals and human
subjects which will interfere with reward circuit
neurons and exert some changes which will make
prone individuals with a dangerous addiction.
Recent studies recommend that Neurohypophyseal hormones like oxytocin and vasopressin [4],
stress hormones [5], and sex hormones [6] will
have an affect reward circuit that has been
observed in animal and human studies. These
hormones can change tolerance, sensitization,
and self-administration. It should be noted that
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study models for investigating behaviors such as
sensitization and self-administration are mostly
assessed by animal studies and in human studies
are sparse [7]. Here we are going to reveal the
different aspects of these hormones within the
addiction process.

2. Neurohypophyseal hormones
The shreds of evidence that support the role of
Neurohypophyseal hormones in addiction come
from animal studies. After subcutaneously, orally
and intracerebroventricularly administration of desglycinamide9-vasopressin (DG-AVP), heroin selfadministration in rats was reduced [8]. This action is
dependent on the sub-regions of the molecular
structure of these hormones because the C-terminal
tripeptide of oxytocin (OXT), prolyl-leucyl-glycinamide (PLG) facilitates the acquisition of selfadministration [9]. In a recent study, it has been
postulated that alcohol and psychostimulant interfere with vasopressin action on the brain and will
result in behavioral abnormalities [10]. Later studies
with morphine brought convincing evidence that
OXT could interfere with addictive behavior via the
reward circuit. The most sensitive areas of the brain
are the hippocampus and basal forebrain [11, 12].
The primary proof which shows OXT interacts with
the mesolimbic dopaminergic system comes from
analgesic treatments with morphine in albino mice
[13]. However, later studies suggest that this impact
can also be seen with the administration of nonanalgesic doses in animal studies [4]. Also in the
presence of nicotine dependence and the emergence of withdrawal signs, after administration of
OXT, the severity of withdrawal signs reduces [14].
A study with heroin showed that the primary action
of OXT is not reinforcing properties of heroin, but
rather on the degree of tolerance and dependence
on heroin in rat models [15]. In a recent study with
alcohol, OXT blocks enhanced motivation for
alcohol abuse through GABAergic transmission in
the central amygdala rat model of alcohol dependence [16]. Despite the presence of OXT receptors
on limbic areas, it has been suggested that OXT may
exert its effects through vasopressin receptors in the
brain of male, adult rats [17]. Also, there are pieces
of evidence that propose OXT may partly inﬂuence
addictive behavior through dopamine receptors in
the basal forebrain of the mouse [18]. In alternative
complementary studies with cocaine and ethanol, it
was shown that OXT can interfere with locomotor
activity, tolerance, and sensitization in mice models
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[19, 20]. Intranasal treatment of OXT has been suggested for clinical trials and clinical trials for OXT
are ongoing as there are many trials in the
clinicaltrial.gov database for OXT and different
drugs such as alcohol, nicotine, and morphine, but
vasopressin in a controlled study showed promising
effects for the facilitation of methadone therapy in a
clinical trial in human subjects [21].

3. Stress hormones
Psychotropic drugs are by themselves are potent
stimulators of stress hormone release. The strong
evidence for the role of addictive drugs as stimulators of stress hormone release comes from an animal study that showed by a single injection of a
bolus dose of Alcohol, the HPA (Hypothalamic-pituitary-adrenal axis) axis will be activated adult
male Sprague-Dawley rats [22]. Nevertheless, this
effect was mostly seen in acute alcohol administration. However, in chronic ethanol stress, tolerance
will occur in the HPA axis that may incline individuals to relapse and heavy drinking [23]. This
relapse results mainly through exacerbation of the
existing ethanol withdrawal signs in the mouse
model [24]. Other studies with alcohol proposed a
role for GABAergic receptors in rodents and
humans [25]. An experiment for this purpose
showed antagonist of the glucocorticoid receptor
can precipitate drug-seeking behavior in a stress
state in a study with psychostimulant drugs and
high alcohol drinkers [26, 27] but in alcoholdependent, individuals reverse occurred [28]. Also,
there is another mechanism for relapse that is due to
neuroadaptation as the result of the compensatory
rise in stress hormones in chronic abusers that
predisposes individuals to relapse to drug-seeking
behavior in studies with alcohol and cocaine in rodent studies [29-31]. In this sense, a wide variety of
differences among individuals as the result of
different region dependent-receptors expressions in
related brain areas exists that were obtained by rodent studies [32]. In a recent study prefrontal cortex
has been shown to be important in this kind of
relapse in different studies in animals and human
subjects [33]. Also, epigenetic changes in glucocorticoid receptors in related brain areas change
addictive behavior that was observed in clinical
studies [34, 35]. Epigenetic changes are described as
the changes that occur in gene expression as the
result of methylation or acetylation without affecting
gene sequences. Epigenetic changes are a new
interesting topic in this sense and are well described
in different studies [36].

4. Sex hormones
A growing body of evidence suggests that sex
hormones are strong mediators of addiction propensity [6, 37]. In animal studies, male rats showed
alcohol-dependence quicker than female rats and
also recover slower than male rats [38]. Differences
in consumption of alcohol were observed that was
lower in male compared to female in adolescent and
adult Sprague-Dawley rats [39]. Also, sex hormones
inﬂuence the acquisition, maintenance, and reinstatement that was well observed both in human
and rodent studies[40]. In human studies, there are
several variations among individuals. Overall
women abusers are fewer than men abusers.
Meanwhile, it should be considered that this may be
dependent on opportunity and chance of access that
is occurred as the result of the sex hormones inﬂuences that were observed in human studies [41,
42]. On the other hand, women tend to increase the
rate of consumption of addictive substances more
rapidly than men [43]. Because higher reactivity of
women to stress, women ﬁnd quitting more difﬁcult
than men [34]. This difference may be reﬂected in
any stages of addition progression such as acquisition, maintenance, dysregulation-escalation, and
relapse. There is evidence that estradiol has a protective role in smoking cessation in women [44]. It is
thought estradiol reduces anxiety and enhances
positive effects. There is strong evidence that sex
hormones inﬂuence reward center maturation and
efﬁcacy that are well observed in rodent and human
studies [45, 46]. However, about the application of
testosterone in individuals with substance use disorder further studies are needed. More studies
should be done to answer the question that what is
the molecular mechanism behind this phenomenon.
Based on recent studies, addictive drugs inﬂuence
different sexes differently that are well documented
in different types of human and rodent studies.
Based on this ﬁnding it can be considered that there
is a wide difference among individuals to react to
addictive drugs [40].

5. Thyroid hormone
Thyroid hormones are essential hormones that are
needed for normal bodily functions. Thyroid
dysfunction is a common ﬁnding in alcoholism.
Subclinical and clinical hypothyroidism may result in
the development of depression and cognitive
impairment. These cognitive and mood abnormalities increase the risk of relapse to addiction. It should
be noted that there are great differences among individuals in this sense [47]. Although there are great
controversies about the TSH (thyroid-stimulating
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hormone) changes in addiction, several studies
indicate TSH changes that result in the alternation of
T3 and T4 although there are studies that there has
been an alternation of T3 and T4 without any significant change of TSH [48]. Some studies suggest the
importance of thyroid hormone replacement for
successful anti-smoking treatment that results in
better cognitive function that is necessary for successful treatment [49]. Some studies suggest the
direct toxic effect of addictive drugs on thyroid
function that result in compensatory activation of the
hypothalamic-pituitary axis with an increase in TRH
(thyrotrophin-releasing hormone) secretion. Thyroid
hormones are known agents that are used for the
improvement of affective disorders [50]. The affective
disorders are prevalent in abusers of drugs. In a user
of heroin, circulating total thyroxin and triiodothyronine and TBG (thyroxin binding globulin) were
increased but reverse triiodothyronine was normal.
Human studies also show, there was a diminished
response of thyrotrophin to thyrotrophin-releasing
hormone and after cessation of heroin, the abnormal
levels came back to the normal state [51]. In a narcotic
study, the results were slightly different and it was
seen that there was a slight increase in total T3 and a
decrease in T3RU, and serum-free T4 level was
decreased [48]. The decrease in thyroid hormone in
drug users may suggest replacement therapy may
reverse some aspects of drug side-effects that may
interfere with successful treatment especially in
heavy users [52]. Animal studies on this topic are
limited.

6. Adipocyte-derived hormones and other
nutritional regulators
Drug addiction is associated with many pathophysiological problems that result in disturbances of
nutritional status [53]. Drug addicts usually suffer
from malnutrition that often is associated with a lack
of food availability [54]. The changes in nutritional
intake result in adipose tissue-derived hormones
and immune disorders that complicate methadone
therapy. In an animal study with methadone, there
was a signiﬁcant abnormality in glucose and lipid
proﬁle [55]. The nutritional imbalances may negatively impair methadone therapy in drug abusers.
Adipose tissue-derived hormones like leptin, adiponectin, and resistin are hormones that regulate
the metabolic state of individuals [56-58]. It is suggested that a far better balance of those hormones
helps a person with a drug use disorder to better
combat the addiction. In a recent study, it has been
shown that in heroin users, basal serum leptin and
adiponectin levels were signiﬁcantly decreased
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while serum resistin concentrations were raised
compared to healthy subjects. It has been suggested
that these changes are independent of nutritional
status and insulin sensitivity among ‘individuals’
[53]. Another hormone in this topic is a-MSH one of
the hypothalamic melanocortins that regulate food
intake [59]. This hormone complicated the opiate
maintenance program. This hormone mainly uses
for food-craving. a-MSH has an antagonistic effect
compared to opioids at many loci including the
hypothalamus. Similarities between drug and eating
addictions have been noted in recent studies. This
hormone has recently got a great interest in getting
better insight into opioids craving [59].
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Also, different hormonal imbalances during methadone therapy may discourage patients to deal with
treatment-related problems that are most relevant
to the speciﬁc hormonal imbalances that are all
mentioned. Therefore, some suggest replacement
therapy with hormones that are mentioned to be
imbalanced during methadone therapy may
encourage individuals to continue treatment. It is
possible by considering the above ﬁndings more
purposeful and promising treatment for patients
with a drug use disorder implemented. Also, the
level of hormones may predict the outcome of
addiction.

Conﬂict of interest
7. Methadone therapy and its complications
Besides the importance of the above hormones in
the treatment of untreated addiction, it would be
helpful for establishing an effective treatment during methadone therapy, hormonal deregulations as
the consequence of methadone therapy to be
considered [60, 61]. After methadone therapy, a
wide variety of hormonal imbalances develops that
has been well observed in human studies. These are
included hypogonadism [62], sexual dysfunction [63,
64], decreased testosterone in serum [65], hyperprolactinemia [66], hypercalcitonemia [67], reduction of thyroid hormone secretion, and TSH
(Thyroid-stimulating hormone) [68], adverse effect
in pregnancy [69], and decreased bone density [70].
Disrespecting these abnormalities during methadone therapy may result in difﬁculties in reaching a
successful treatment. Also, this misunderstanding
may cause people with a drug use disorder to
relapse to drug use for preventing the concurrence
of such undesired side-effects. Some clinical studies
have recommended patients may get beneﬁt from
hormonal replacement therapy, especially for sexual
dysfunction [62]. However, some other clinical
studies suggest the application of buprenorphine as
the replacement therapy of methadone may reduce
the side-effects [71].

8. Conclusion
Overall, it can be concluded that neurohypophyseal hormones, stress hormones, and sex hormones
can interfere with tolerance, sensitization, and binge
intake. About other hormones such as thyroid hormones, more studies should be done to reveal the
different aspects of them in different contexts that
improve high-risk behavior. Adipocyte-derived
hormones seem to have a protective effect in the
abstinence period especially in heroin users by
improving the nutritional status of the individuals.
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